Rare Neurological Disease Treatment Market, By Drug Type (Biologics and Small Molecules), By Mode of Administration (Injectables, Oral and Other Modes of Administration), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI484021 | Publish Date: August 2023 | No. of Pages: 168

Global Rare Neurological Disease Treatment Market Overview

The global rare neurological illness treatment market is predicted to grow significantly in the years ahead, with a forecast period spanning 2020 to 2030. Increased awareness of these conditions, advancements in healthcare and neurobiology technology, and expedited approvals of innovative treatment approaches are all aspects that will contribute to the global market's growth. Rare neurological disorders (RNDs) go undiagnosed far too often, and appropriate therapy is frequently unavailable. There are around 5000–8000 uncommon diseases, and 5–8% of the European population is affected by one, with many of them having neurological signs. Some neurological illnesses include Reflex Sympathetic Dystrophy Syndrome, Battaglia-Neri syndrome, Creutzfeldt - Jakob disease, Agnosia, Aicardi syndrome, and Aicardi-Goutieres syndrome. However, there are various roadblocks to diagnosing uncommon neurological diseases, including a lack of public knowledge of rare neurological diseases. Rare diseases are putting a major strain on healthcare and the economy all around the world. For Instance, According to the National Organization for Rare Disorders (NORD) Report, there are an estimated 7,000 recognised rare diseases that cause significant morbidity and mortality in the 25 million Americans who are affected. In addition, it's assumed that around a third of these have neurological components and symptoms. Rare neurological illnesses are becoming more common, and governments around the world are promoting faster progress. The Global Rare Neurological Disease Treatment Market accounted for US$ 8931.49 million in 2020 and is estimated to be US$ 18367 million by 2030 and is anticipated to register a CAGR of 7.50%.

Global Rare Neurological Disease Treatment Market Dynamics

Rising activities of research and development to find remedies for such ailments will drive the growth of the Market

The overall development of the worldwide rare neurological illness treatment market is influenced by a number of variables. The rising activities of research and development to find remedies for such ailments has been one of the primary driving factors for the worldwide market's rise. Rare neurological illnesses have become more common in recent years all around the world. The majority go unreported or are misdiagnosed. The absence of appropriate therapy is the most notable driving factor for the market's main players, which will assist it develop in the forecast period's approaching years. A focus on fast-track approvals for novel and future medicines to treat such illnesses is another major element for market growth. Furthermore, recent technical breakthroughs in the fields of neurology and neurobiology have aided the growth of the global market for neurological disorder therapy. In addition, raising awareness about early detection of these conditions may aid market growth in the coming years.

The lack of a standard treatment to cure these problems has been a major stumbling block to the global neurological disease treatment market's expansion.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Rare Neurological Disease Treatment Market Segmentation

 

                                            Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global Rare Neurological Disease Treatment Market is segmented based on drug type, mode of administration and region.

On the basis of Drug Type, the Global Rare Neurological Disease Treatment Market is segmented into Biologics and Small Molecules. Based on Mode of Administration, the target market is segmented into Injectables, Oral and Other Modes of Administration

Regional Insights:

 

                                                              Source: Prophecy Market Insights

                                   

On region the Global Rare Neurological Disease Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of the availability of reimbursement, the rising frequency of rare neurological disorders, and increased research and development in this area, North America is likely to hold a significant market position in the worldwide rare neurological disease treatment market. According to the Center for Uncommon Neurological Disease Research Report, roughly 200,000 people in the United States suffer from rare neurological illnesses. In addition, rising healthcare spending and the presence of well-established healthcare infrastructure are both contributing to the overall regional market's growth.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Drug Type- Biologics and Small Molecules

By Mode of Administration– Injectables, Oral and Other Modes of Administration

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Rare Neurological Disease Treatment Market report based on Drug Type, Mode of Administration and region.

                                        

Global Rare Neurological Disease Treatment Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Rare Neurological Disease Treatment Market Key Players

The key players operating in the rare neurological disease treatment market are include CSL Ltd, Kedrion Biopharma Inc., US WorldMeds LLC (Solstice Neurosciences LLC), Merz Pharma GmbH & Co. KGaA, Aquestive Therapeutics Inc., Bayer AG, Pfizer Inc., Novartis AG, Merck & Co. Inc. (EMD Serono Inc.), and Jazz Pharmaceuticals PLC.

Global Rare Neurological Disease Treatment Market Company Profile

  • CSL Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Kedrion Biopharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • US WorldMeds LLC (Solstice Neurosciences LLC)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merz Pharma GmbH & Co. KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Aquestive Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Rare Neurological Disease Treatment Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Rare Neurological Disease Treatment Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Drug Type
      • Market Snippet, By Mode of Administration
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Rare Neurological Disease Treatment Market, By Drug Type, 2020 – 2030, (US$ Mn)
    • Overview         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Biologics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Small Molecule
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Rare Neurological Disease Treatment Market, By Mode of Administration, 2020 – 2030, (US$ Mn)
    • Overview                                                
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Injectables
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Orals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Rare Neurological Disease Treatment Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Mode of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Mode of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Mode of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Mode of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Mode of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
  • CSL Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Kedrion Biopharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • US WorldMeds LLC (Solstice Neurosciences LLC)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merz Pharma GmbH & Co. KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Aquestive Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Rare Neurological Disease Treatment Market is segmented based on drug type, mode of administration and region.

Rising activities of research and development to find remedies for such ailments is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the rare neurological disease treatment market are include CSL Ltd, Kedrion Biopharma Inc., US WorldMeds LLC (Solstice Neurosciences LLC), Merz Pharma GmbH & Co. KGaA, Aquestive Therapeutics Inc., Bayer AG, Pfizer Inc., Novartis AG, Merck & Co. Inc. (EMD Serono Inc.), and Jazz Pharmaceuticals PLC.